Literature DB >> 32505358

A novel molecular mechanism responsible for phosphorylation-independent desensitization of G protein-coupled receptors exemplified by the dopamine D3 receptor.

Mei Zheng1, Xiaohan Zhang1, Ningning Sun1, Xiao Min1, Srijan Acharya1, Kyeong-Man Kim2.   

Abstract

GRK-mediated receptor phosphorylation followed by association with β-arrestins has been proposed to be the molecular mechanism involved in the desensitization of G protein-coupled receptors (GPCRs). However, this mechanism does not explain the desensitization of some GPCRs, such as dopamine D3 receptor (D3R), which does not undergo GRK-mediated phosphorylation. Loss-of-function approaches and mutants of dopamine D2 receptor and D3R, which exhibit different desensitization properties, were used to identify the cellular components and processes responsible for desensitization. D3R mediated the recruitment of Mdm2 to the cytosol, which resulted in the constitutive ubiquitination of β-arrestin2 in the resting state. Under desensitization conditions, cytosolic Mdm2 returned to the nucleus, resulting in the deubiquitination of cytosolic β-arrestins. Deubiquitinated β-arrestins formed a tight complex with Gβγ, thereby sequestering it, causing interference in D3R signaling. In conclusion, this study shows that β-arrestins, depending on their ubiquitination status, control the G protein cycling by regulating their interactions with Gβγ. This is a novel mechanism proposed to explain how certain GPCRs can undergo desensitization without receptor phosphorylation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Desensitization; Dopamine D(3) receptor; GPCR; Gβγ; Mdm2; β-Arrestin

Year:  2020        PMID: 32505358     DOI: 10.1016/j.bbrc.2020.05.197

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders.

Authors:  Béla Kiss; István Laszlovszky; Balázs Krámos; András Visegrády; Amrita Bobok; György Lévay; Balázs Lendvai; Viktor Román
Journal:  Biomolecules       Date:  2021-01-14

2.  Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor.

Authors:  Pramisha Adhikari; Bing Xie; Ana Semeano; Alessandro Bonifazi; Francisco O Battiti; Amy H Newman; Hideaki Yano; Lei Shi
Journal:  Biomolecules       Date:  2021-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.